Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

980
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
980
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

3.0K
The pathophysiology of pneumonia involves the following steps:
3.0K
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

3.1K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
3.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.3K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Different Training Modalities on Circulating Irisin Levels in Overweight and Obesity Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Sports medicine (Auckland, N.Z.)·2026
Same author

Effectiveness of resistance training and pain reprocessing therapy in female flight attendants with chronic low back pain: a study protocol for a randomized controlled trial.

Pain management·2026
Same author

Muscle Insulin Resistance Elicits Muscle Atrophy in Obesity.

Current obesity reports·2025
Same author

Insights on the Tunisian Prickly Pear Molasses as a Potential Antifibrotic and Antioxidant Candidate against Lung Fibrosis.

Chemistry & biodiversity·2024
Same author

Biochemical Composition, Antioxidant Capacity and Protective Effects of Three Fermented Plants Beverages on Hepatotoxicity and Nephrotoxicity Induced by Carbon Tetrachloride in Mice.

Indian journal of microbiology·2024
Same author

<i>Phœnix dactylifera,</i> L. seed oil alleviates Bleomycin-induced pulmonary fibrosis and oxidative stress in <i>Wistar</i> rats.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals·2024

Related Experiment Video

Updated: Feb 9, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

1.1K

Idiopathic pulmonary fibrosis:Pathophysiological data.

Khadija Ayed, Raja Serairi Beji, Saloua Jameleddine

    La Tunisie Medicale
    |June 7, 2018
    PubMed
    Summary

    Inflammation

    Area of Science:

    • Pulmonary Medicine
    • Pathophysiology
    • Immunology

    Background:

    • Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease.
    • The role of inflammation in IPF pathogenesis is debated.
    • Traditional views suggest IPF is not primarily inflammatory.

    Purpose of the Study:

    • To explore the controversial role of inflammation in IPF.
    • To propose alternative mechanisms for inflammation's involvement in IPF.
    • To challenge the notion that IPF is solely a fibroblast dysfunction.

    Main Methods:

    • Review of existing literature on IPF pathology and treatment.
    • Analysis of the limitations of traditional inflammatory models in IPF.
    • Synthesis of emerging concepts like epithelial-mesenchymal transition.

    More Related Videos

    Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
    06:29

    Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

    Published on: May 5, 2023

    3.1K
    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    1.8K

    Related Experiment Videos

    Last Updated: Feb 9, 2026

    Refined Murine Model of Idiopathic Pulmonary Fibrosis
    07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.1K
    Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo
    06:29

    Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo

    Published on: May 5, 2023

    3.1K
    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
    06:03

    Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

    Published on: May 9, 2025

    1.8K

    Main Results:

    • Classic IPF pathology shows minimal inflammation.
    • Immunosuppressive therapies are ineffective for IPF.
    • Fibroblast dysfunction and epithelial-mesenchymal transition are key factors.

    Conclusions:

    • Inflammation may play a critical, albeit non-traditional, role in IPF.
    • Five novel hypotheses for inflammation's role are proposed.
    • Further research into these mechanisms is warranted for IPF treatment.